Ignite Creation Date:
2024-05-06 @ 12:33 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03787251
Status:
WITHDRAWN
Last Update Posted:
2022-04-19
First Post:
2018-12-20
Brief Title:
A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With Apatinib
Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization Data
Organization:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Class:
OTHER
Study ID:
Nanjing Drum Tower Hospital
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Lead Sponsor Class:
OTHER
Responsible Party:
Wei Ren
Responsible Party Title:
Deputy Chief Physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Old Name:
None
Old Organization:
None